Morgane Le Bras

3.5k total citations
43 papers, 2.3k citations indexed

About

Morgane Le Bras is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Morgane Le Bras has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Hematology. Recurrent topics in Morgane Le Bras's work include Retinoids in leukemia and cellular processes (8 papers), Mitochondrial Function and Pathology (7 papers) and Cell death mechanisms and regulation (6 papers). Morgane Le Bras is often cited by papers focused on Retinoids in leukemia and cellular processes (8 papers), Mitochondrial Function and Pathology (7 papers) and Cell death mechanisms and regulation (6 papers). Morgane Le Bras collaborates with scholars based in France, Lebanon and Singapore. Morgane Le Bras's co-authors include Catherine Brenner, Hugues de Thé, Santos A. Susín, Valérie Lallemand-Breitenbach, Shazib Pervaiz, Guido Kroemer, Aurélien Deniaud, Gwénaël Jan, Omar Ferhi and Evelyne Maillier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Morgane Le Bras

41 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgane Le Bras France 23 1.7k 302 271 263 261 43 2.3k
Enriqué Cepero United States 9 1.5k 0.9× 633 2.1× 308 1.1× 153 0.6× 354 1.4× 11 2.5k
Justin Kale Canada 13 1.6k 0.9× 329 1.1× 267 1.0× 101 0.4× 225 0.9× 15 2.2k
TW Mak Canada 9 1.4k 0.8× 387 1.3× 448 1.7× 129 0.5× 249 1.0× 20 2.5k
Walter K. Nishioka United States 16 1.6k 0.9× 542 1.8× 470 1.7× 239 0.9× 196 0.8× 19 2.5k
Lijun Yang China 32 1.8k 1.1× 277 0.9× 392 1.4× 112 0.4× 591 2.3× 99 2.6k
Federica Gibellini United States 18 1.1k 0.6× 187 0.6× 188 0.7× 139 0.5× 234 0.9× 27 2.1k
Sun‐Hee Leem South Korea 32 2.1k 1.3× 394 1.3× 220 0.8× 158 0.6× 398 1.5× 126 3.0k
Laurence Dubrez France 28 2.2k 1.3× 645 2.1× 561 2.1× 139 0.5× 335 1.3× 51 2.9k
Roger T. Snowden United Kingdom 26 1.7k 1.0× 419 1.4× 551 2.0× 122 0.5× 240 0.9× 50 2.7k
Samuel G. Mackintosh United States 30 2.2k 1.3× 290 1.0× 244 0.9× 73 0.3× 210 0.8× 79 2.9k

Countries citing papers authored by Morgane Le Bras

Since Specialization
Citations

This map shows the geographic impact of Morgane Le Bras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgane Le Bras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgane Le Bras more than expected).

Fields of papers citing papers by Morgane Le Bras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgane Le Bras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgane Le Bras. The network helps show where Morgane Le Bras may publish in the future.

Co-authorship network of co-authors of Morgane Le Bras

This figure shows the co-authorship network connecting the top 25 collaborators of Morgane Le Bras. A scholar is included among the top collaborators of Morgane Le Bras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgane Le Bras. Morgane Le Bras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasr, Rihab, et al.. (2023). 71P MicroRNA (miRNA) a putative biomarker to better define the molecular apocrine breast cancer (MABC) subtype. ESMO Open. 8(1). 101294–101294. 1 indexed citations
2.
Bras, Morgane Le, et al.. (2023). ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!. Biomedicines. 11(8). 2300–2300. 4 indexed citations
3.
Brabencová, Eva, Christian Garbar, Armand Bensussan, et al.. (2022). The NFAT3/RERG Complex in Luminal Breast Cancers Is Required to Inhibit Cell Invasion and May Be Correlated With an Absence of Axillary Lymph Nodes Colonization. Frontiers in Oncology. 12. 804868–804868.
4.
Herviou, Pauline, Morgane Le Bras, Corinne Hiéblot, et al.. (2020). hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma. Nature Communications. 11(1). 2661–2661. 75 indexed citations
5.
Niwa‐Kawakita, Michiko, et al.. (2017). PML is a ROS sensor activating p53 upon oxidative stress. The Journal of Experimental Medicine. 214(11). 3197–3206. 81 indexed citations
6.
Ablain, Julien, Aurélien de Reyniès, Laurent Pérès, et al.. (2014). Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. Blood. 124(25). 3772–3780. 33 indexed citations
7.
Thé, Hugues de, et al.. (2013). PML, SUMOylation, and Senescence. Frontiers in Oncology. 3. 171–171. 37 indexed citations
8.
Bras, Morgane Le, et al.. (2011). RXR, un cofacteur essentiel à la transformation dans les leucémies aiguës promyélocytaires. médecine/sciences. 27(11). 973–978. 3 indexed citations
9.
Barbier, Sandrine, Laurent Châtre, Morgane Le Bras, et al.. (2009). Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica. 94(4). 507–517. 21 indexed citations
10.
Yuan, Hao, Jun Zhou, Min Deng, et al.. (2009). Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish. Cell Research. 20(2). 185–196. 38 indexed citations
11.
Bras, Morgane Le, Annie Borgne‐Sanchez, Zahia Touat, et al.. (2006). Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2. Cancer Research. 66(18). 9143–9152. 80 indexed citations
12.
Britzen‐Laurent, Nathalie, Anne Gibaud, Morgane Le Bras, et al.. (2006). Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis. 27(6). 1266–1272. 53 indexed citations
13.
Jacotot, Étienne, Aurélien Deniaud, Annie Borgne‐Sanchez, et al.. (2006). Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1757(9-10). 1312–1323. 25 indexed citations
14.
Tarze, Agathe, Aurélien Deniaud, Morgane Le Bras, et al.. (2006). GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene. 26(18). 2606–2620. 274 indexed citations
15.
Bras, Morgane Le, Aurélien Deniaud, Gaël Lecellier, Guido Kroemer, & Catherine Brenner. (2005). Ant2. 1 indexed citations
16.
Brenner, Catherine, Morgane Le Bras, & Guido Kroemer. (2003). Insights into the Mitochondrial Signaling Pathway: What Lessons for Chemotherapy?. Journal of Clinical Immunology. 23(2). 73–80. 21 indexed citations
17.
Bras, Morgane Le, Karim Bensaad, & Thierry Soussi. (2003). Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway. Oncogene. 22(32). 5082–5090. 9 indexed citations
18.
Bensaad, Karim, Morgane Le Bras, Sabrina Strano, et al.. (2003). Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73. Journal of Biological Chemistry. 278(12). 10546–10555. 31 indexed citations
19.
Rabenja, Fahafahantsoa Rapelanoro, et al.. (1997). EPIDIDYMITE AU COURS DE LA MALADIE DE BEHCET. La Presse Médicale. 26(29).
20.
Jaubert, D, Michel Longy, Marie-Christine Delmas, & Morgane Le Bras. (1980). Portal hypertension in schistosomiasis.. 40(1). 59–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026